← Back
Data updated: Jul 17, 2026
US ARMY WALTER REED
Pharma Pharmaceuticals
US ARMY WALTER REED is a pharmaceutical company with 1 FDA-approved products.
1989
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Upcoming FDA Decisions
Full Calendar → Aug 13, 2026 — LNTH
26d Oct 17, 2026 — Phentolamine ophthalmic solution 0.75%
US ARMY WALTER REED's Key Drugs
US ARMY WALTER REED's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
US ARMY WALTER REED's Recent FDA Approvals
New NDA/BLA approvals for US ARMY WALTER REED over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
US ARMY WALTER REED's Therapeutic Areas
Disease areas where US ARMY WALTER REED has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
US ARMY WALTER REED Pipeline Snapshot
Active clinical trials for US ARMY WALTER REED across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1989-05-02
- Latest
- 1989-05-02
- Applications
- 1